First Niagara Bank’s Quest Diagnostics DGX Stock Holding History

First Niagara Bank’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3,600	Closed	-$221K	–	200
2015 Q3	$221K	Sell	3,600 -16	-0.4%	-$1.12K	0.06%	197
2015 Q2	$262K	Buy	3,616 +16	+0.4%	+$1.18K	0.06%	202
2015 Q1	$277K	Hold	3,600	–	–	0.06%	189
2014 Q4	$241K	Hold	3,600	–	–	0.05%	209
2014 Q3	$218K	Hold	3,600	–	–	0.05%	212
2014 Q2	$211K	Sell	3,600 -2	-0.1%	-$117	0.04%	224
2014 Q1	$209K	Buy	+3,602	New	+$193K	0.04%	223
2013 Q4	–	Sell	-3,608	Closed	-$223K	–	227
2013 Q3	$223K	Sell	3,608 -4	-0.1%	-$239	0.05%	215
2013 Q2	$219K	Buy	+3,612	New	+$215K	0.05%	220

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Niagara Bank's DGX Position: Q4 2015 in Review

First Niagara Bank sold out of Quest Diagnostics (DGX) in Q4 2015, closing a stake of 3,600 shares — an estimated $221K sold.

First Niagara Bank first reported a position in DGX in Q2 2013 and held it in 9 quarters. The position peaked at $277K in Q1 2015. 535 funds tracked by Wall St. Rank hold DGX as of Q4 2015.

First Niagara Bank reported no remaining Quest Diagnostics position as of Q4 2015 after selling out during the quarter.
First Niagara Bank sold 3,600 Quest Diagnostics shares in Q4 2015, an estimated $221K.
First Niagara Bank first reported a position in Quest Diagnostics in Q2 2013 and held it in 9 quarters.
First Niagara Bank's Quest Diagnostics position peaked at $277K in Q1 2015.
535 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2015.

Based on First Niagara Bank's 13F filing for Q4 2015, filed 10 Feb 2016.